- Home
- VSTM vs NTRB Comparison
VSTM vs NTRB Comparison
Compare VSTM & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VSTM | NTRB |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.7M | 54.1M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | VSTM | NTRB |
|---|---|---|
| Price | $5.83 | $3.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 11.0K |
| Earning Date | 03-04-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,914,000.00 | N/A |
| Revenue This Year | $254.18 | $30.17 |
| Revenue Next Year | $99.39 | $3,394.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 209.14 | N/A |
| 52 Week Low | $4.01 | $3.64 |
| 52 Week High | $11.25 | $11.68 |
Technical Indicators
Market Signals| Indicator | VSTM | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 45.83 | 44.47 |
| Support Level | $5.56 | $3.64 |
| Resistance Level | $6.79 | $4.50 |
| Average True Range (ATR) | 0.39 | 0.24 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 41.13 | 44.91 |
Price Performance
Historical ComparisonAbout VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.